HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro.
Uptake of zymosan A particles by human umbilical vein endothelial cells (HUVEC) and its effect on cellular cytokine and oxygen radical production was examined. HUVEC took up more serum-opsonized than -unopsonized zymosan as demonstrated by flow cytometry with fluorescence-labeled particles. The former uptake was inhibited in the presence of anti-C3c antibodies and thus complement-mediated. It probably occurred via CR1 (CD35), although participation of other receptors cannot be ruled out. Scanning electron microscopy indicated that HUVEC with fully internalized zymosan particles were damaged. Prolonged incubation of both serum-opsonized and -unopsonized zymosan particles with HUVEC induced increased secretion of the proinflammatory cytokines IL-6 and IL-8 to the cell culture supernatants, but had no effect on production of oxygen radicals. The results confirm previous reports that EC can internalize yeast and other pathogens and points to complement as a mechanism of uptake, but illustrates that the cells may be damaged in the process. Moreover, EC may participate in the anti-infection defense effort by secreting proinflammatory and chemotactic cytokines in response to the contact with pathogens.
Langeggen
Harald
H
Research Forum and Department of Pediatrics, Ullevål University Hospital, Kirkevej Kirkeveien 166, 0404 Oslo, Norway.
Namork
Ellen
E
Johnson
Egil
E
Hetland
Geir
G
D039481:CD11b Antigen / Q000276:immunology; D002478:Cells, Cultured; D003167:Complement Activation / Q000276:immunology*; D004730:Endothelium, Vascular / Q000276:immunology / Q000378:metabolism* / Q000648:ultrastructure; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis / Q000378:metabolism*; D016209:Interleukin-8 / Q000096:biosynthesis / Q000378:metabolism*; D008855:Microscopy, Electron, Scanning; D009895:Opsonin Proteins / Q000276:immunology / Q000378:metabolism; D010587:Phagocytosis / Q000276:immunology; D017463:Receptors, Complement 3b / Q000276:immunology; D013481:Superoxides / Q000378:metabolism; D014471:Umbilical Veins; D015054:Zymosan / Q000276:immunology / Q000493:pharmacokinetics*
D039481:CD11b Antigen; D015850:Interleukin-6; D016209:Interleukin-8; D009895:Opsonin Proteins; D017463:Receptors, Complement 3b; D013481:Superoxides; D015054:Zymosan